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Genotoxic colibactin-producing pks+ Escherichia coli induce DNA double-strand breaks,
mutations, and promote tumor development in mouse models of colorectal cancer (CRC).
Colibactin’s distinct mutational signature is reflected in human CRC, suggesting a causal link.
Here, we investigate its transformation potential using organoids from primary murine colon
epithelial cells. Organoids recovered from short-term infection with pks+ E. coli show char-
acteristics of CRC cells, e.g., enhanced proliferation, Wnt-independence, and impaired dif-
ferentiation. Sequence analysis of Wnt-independent organoids reveals an enhanced
mutational burden, including chromosomal aberrations typical of genomic instability.
Although we do not find classic Wnt-signaling mutations, we identify several mutations in
genes related to p53-signaling, including miR-34a. Knockout of Trp53 or miR-34 in organoids
results in Wnt-independence, corroborating a functional interplay between the p53 and Wnt
pathways. We propose larger chromosomal alterations and aneuploidy as the basis of
transformation in these organoids, consistent with the early appearance of chromosomal
instability in CRC.
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Colorectal cancer (CRC) is the second leading cause ofcancer-related mortality worldwide. The genetic landscapeof mutations that drive carcinogenesis is well explored and
involves the Wnt, KRAS, TGF-β, and p53 pathways1. Combina-
tions of mutations in these pathways are responsible for the
transformation of epithelial cells2,3, and constitutively active Wnt
signaling is considered to be a crucial feature of almost all CRCs4.
Wnt signaling drives proliferation of colon cells and is physio-
logically active only in the stem cell compartment, while
differentiated cells lack Wnt signaling5. Experimental and
patient-derived data indicate that constitutively active Wnt
signaling is an early event in the CRC cascade, often achieved by
mutation of APC and subsequent loss of heterozygosity (LOH)1,6.
Although, this holds true for sporadic cases of CRC, cases driven
by chronic inflammatory disorders, such as ulcerative colitis or
Crohn’s colitis, are associated with a distinct mutational profile,
in which mutations in the p53 pathway are thought to occur as an
early event7–10. While many of the mutations in driver genes are
due to single nucleotide substitutions and small insertion and
deletions, chromosomal aberrations are frequent in CRC and
found in the majority of cases4. Chromosomal instability (CIN) is
often attributed to cell-intrinsic causes like spindle assembly
checkpoint defects11, but the exact mechanisms leading to CIN
are mostly unknown.
Recent data suggest that environmental factors are important
drivers of CRC and that the colonic microbiota plays an impor-
tant role in both the development and progression of CRC12–14.
In addition to microbial factors that induce inflammation and
therefore contribute to carcinogenesis by triggering oxidative
stress or changes in the stem cell niche, certain bacteria that
colonize the gut appear to directly affect the genomic integrity of
epithelial cells through genotoxins. In this context, colibactin is a
prominent genotoxin produced by several Enterobacteriaceae
members, such as E. coli belonging to phylogenetic group B2.
This toxin is a polyketide/nonribosomal peptide hybrid, encoded
by the pks pathogenicity island. Infection of eukaryotic cell lines
with pks+ E. coli was shown to cause DNA double-strand breaks
(DSBs), leading to megalocytosis and cell cycle arrest15. Short
exposure of an intestinal epithelial cell line to pks+ E. coli has
been reported to cause genomic instability and anchorage-
independent growth16. Significant enrichment of pks gene clus-
ters has been observed in CRC metagenomes13. An increase in
colonic mucosa-associated E. coli that possess the pks gene has
been observed in inflammatory bowel disease (IBD), familial
adenomatous polyposis (FAP), and CRC patients17–19. Colibactin
alkylates DNA through covalent modifications and forms stable
adenine-colibactin adducts in cultured mammalian cells and
in vivo20–22. It has also been shown to leave a specific mutational
signature in CRC patients23,24. Moreover, pks+ E. coli enhance
tumorigenesis in different murine models of FAP and CRC, such
as mice heterozygous for Apc18, interleukin-10–deficient (Il10−/−)
germ-free mice17, and the azoxymethane/dextran sulfate sodium
(AOM/DSS) model25. Notably, in these mouse models, tumors
can also arise in the absence of colibactin, leaving it uncertain
whether colibactin merely enhances tumorigenesis or whether it
can also play a causative role. To study genomic instability caused
by pks+ E. coli in vitro, infections have only been performed with
transformed or immortalized cell lines, and it remains unclear
whether healthy primary colon epithelial cells respond to infection
in the same way.
To address this, we developed primary cell culture models
derived from normal murine colon epithelial cells. We infected
organoids as well as polarized monolayers derived from primary
colon epithelial cells with pks+ E. coli or an isogenic mutant that
is defective for colibactin synthesis. In these models, we were able
to reproduce early responses to infection, including DSBs and
development of megalocytosis—effects unique to strains with a
functional pks island. Furthermore, we examined whether
colibactin-induced DNA damage after short-term infection
causes genomic instability, mutations, or changes in niche
dependence of colon organoids. We specifically investigated Wnt-
independence due to its clinical relevance. Our findings reveal
that the genotoxic effect of colibactin is sufficient to rapidly cause
genomic aberrations in primary colon cells and to induce mul-
tiple features of transformation reminiscent of CRC. These
transformed cells did not exhibit the typical colibactin mutational
signature, suggesting that improper repair of colibactin-induced
cross-links after short exposure to the bacteria can lead to copy
number variations (CNV) and other mutations. Accordingly,
chromosomal aberrations causing aneuploidy induced by coli-
bactin are sufficient to cause primary cell transformation and
precede detectable genomic imprinting of the colibactin muta-
tional signature. The transforming capacity of colibactin-
producing E. coli may thus be higher than what is estimated
from the presence of the mutational signature alone.
Results
pks+ E. coli cause DNA damage, megalocytosis, and formation
of multinucleated cells in primary colon epithelial cell cultures.
To test whether the previously observed phenotypes of mega-
locytosis and DNA damage can be reproduced upon infection of
human colon adenocarcinoma Caco-2 cells with the colibactin-
producing (pks+) wild-type (WT) M1/5 E. coli, we infected this
cell line for 3 h at multiplicity of infection (MOI) 20. To ensure
the effects were colibactin-specific, we used the E. coli ΔclbR
mutant strain26, which is defective for colibactin synthesis, as the
negative control. Cells were immunostained for γH2AX, an early
response to DNA damage required for the recruitment of DNA
damage repair proteins. We observed γH2AX-positive cells, as
well as megalocytosis and multinucleated cells in cultures infected
with pks+ WT E. coli, while cultures infected with the mutant
strain exhibited significantly less DNA damage (Fig. 1a). We next
examined whether similar phenotypic changes are also observed
after infection of primary cells. As it is difficult to image mega-
locytosis and multinucleated cells in organoids, we utilized
mucosoids27, polarized epithelial monolayers grown in air–liquid
interface28. For this, mouse primary colon cells were first grown
as conventional 3D organoids29, then sheared into single cells and
seeded on collagen-coated polycarbonate filter inserts. Cultures in
air–liquid interface form highly polarized monolayers, with
secreted mucus accumulating on the apical side, similar to the
epithelium in vivo (Fig. 1b). Immunolabeling of cultures shows
that the cells express β-catenin and MUC2, the typical mucin of
the colon (Fig. 1c, top). They became fully polarized, as indicated
by basolateral E-cadherin staining and the presence of eccentric
nuclei, and focally expressed Ki67, a marker of proliferating cells
(Fig. 1c, bottom). After infection at MOI 5 for 3 h, we detected
γH2AX-positive cells, megalocytosis, and multinucleated cells,
similar to the phenotypes seen in Caco-2 cells (Fig. 1d). These
phenotypes were not seen after infection with the ΔclbR mutant.
Thus, primary cells show a similar phenotypic response to coli-
bactin as previously observed in cell lines.
We also infected murine colon organoids with pks+ E. coli at
MOI 5 for 3 h. Organoids were first broken up, so that both the
basal and apical sides were exposed to the bacteria. Whole-mount
immunofluorescence labeling was carried out 3 days later, after
organoids had re-formed. Again, we observed γH2AX-positive
cells only after infection with the pks+ WT E. coli strain,
indicating that this system is suitable for studying the effects of
colibactin on primary cells (Fig. 1e). To confirm that the effects
observed in the context of primary cell infection were not due to
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differences in infectivity between WT and ΔclbR mutant E. coli,
we performed colony-forming unit (CFU) analysis upon infection
of organoids, confirming equal colonization rate (Fig. 1f).
To further confirm the presence of DSBs, we measured
damaged DNA in murine colon organoid cells by neutral comet
assay. The amount of DNA damage caused by infection with pks+
WT E. coli was similar to that induced by treatment with
etoposide, used as a positive control. The ΔclbR mutant caused
only minimal DNA damage compared to the non-infected
condition (Fig. 1g). Infection of human colon organoids also
resulted in γH2AX-positive cells and caused significantly more
DNA damage in neutral comet assay only in the pks+ WT E. coli-
infected condition (Supplementary Fig. 1a, b). Furthermore, upon
infection with pks+ WT E. coli, human colon organoids showed
nuclear expression of the DSB repair proteins, phospho-
checkpoint kinase 2 (Chk2) (Supplementary Fig. 2a), and p53-
binding protein 1 (53BP1) (Supplementary Fig. 2b), indicating
that DSB repair is activated in response to colibactin. We therefore
conclude that primary cells show DNA damage, megalocytosis,
formation of multinucleated cells, and expression of DSB repair
proteins upon exposure to pks+ E. coli, which is dependent on the
synthesis of colibactin.
Wnt-independent growth of organoids after infection with
pks+ E. coli. Although DSBs are known to cause apoptosis or
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have been shown to continue to proliferate in the presence of
DNA damage after infection with pks+ E. coli16. We wanted to
explore the response of non-immortalized primary cells equipped
with normal DNA repair mechanisms. Primary polarized epi-
thelial monolayers were infected with pks+ E. coli and immu-
nolabeled for γH2AX and Ki67. After 3 h of infection, several cells
were double-positive for γH2AX and Ki67, indicating that they
proliferated despite DNA damage. In contrast, monolayers that
were treated with cisplatin, a chemotherapeutic agent known to
cross-link DNA and form cytotoxic adducts similar to coli-
bactin30, contained no double-positive cells (Supplementary
Fig. 3a). Immunofluorescence also showed a lower expression of
γH2AX for cisplatin-treated cells, which was compatible with the
neutral comet assay results (Supplementary Fig. 3b).
Cell proliferation in the presence of incompletely repaired
DNA damage can cause somatic mutations, which could
potentially lead to independence from niche factors. Such niche
escape is a hallmark of cancer organoids2,3. To assess their
organoid-forming capacity, we infected organoids at MOI 5 for 3
h, re-seeded them in Matrigel and treated them with gentamicin
to kill the bacteria. To determine the extent of cell death, we
performed an organoid-forming assay where 50,000 cells were
seeded in each condition. We observed that the organoid-forming
efficiency for pks+ WT E. coli-infected organoids was reduced by
about 40%, but there was no difference between WT and ΔclbR
mutant E. coli-infected conditions (Fig. 2a). As the earliest and
most frequently observed mutations in CRC are ones that lead to
constitutive Wnt pathway activation, at the next passage we re-
seeded the organoids into complete 3D medium, which contains
both Wnt and the Wnt agonist CHIR99021, as well as into
medium lacking these two factors (Fig. 2b). We noticed that non-
infected and ΔclbR mutant-infected organoids failed to re-grow in
Wnt-free medium, while in the pks+ WT E. coli-infected
condition a few organoids did re-form (Fig. 2c). These Wnt-
independent organoids could be further passaged and expanded.
Thus, a short exposure of primary cells to colibactin-producing E.
coli was sufficient to cause somatic adaptation that led to the
generation of Wnt-independent clones.
We also performed experiments with E. coli Nissle 1917, which
is widely used as a probiotic and known to harbor the pks island.
Neutral comet assay demonstrated that Nissle 1917 caused fewer
DSBs compared to the M1/5 strain, but more than was seen in the
non-infected and the E. coli Nissle 1917 ΔclbB mutant-infected
conditions (Supplementary Fig. 4a). Furthermore, we analyzed
the cross-linking capacity of these two strains. WT bacteria were
added to 1.5 µg of pfdA8 plasmid DNA at CFUs ranging from
1*106 to 10*106. A single CFU of 120*106 was added for the
mutant strains. A band at 3.4 kb indicates the presence of cross-
linked DNA. Although both strains are commensal E. coli, the
M1/5 strain showed a higher amount of cross-linked DNA
compared to the Nissle 1917 strain. The absence of a band at 3.4
kb for the mutant strains indicated that they did not cross-link
DNA (Supplementary Fig. 4b). Upon infection of murine colon
organoids, no Wnt-independent organoids were observed in the
E. coli Nissle 1917-infected condition, whereas the E. coli M1/
5 strain once again generated Wnt-independent organoids.
Additionally, treatment with etoposide or cisplatin also did not
generate Wnt-independent organoids (Supplementary Fig. 4c).
Therefore, the genotoxicity varies between strains of pks+ E. coli
and also as compared to other DNA damaging agents.
Wnt-independent organoids exhibit increased organoid for-
mation capacity, higher proliferation, and longevity. To char-
acterize the consequences of infection on organoid growth, we
measured the organoid-forming capacity of non-infected, pks+
WT E. coli-infected and ΔclbR mutant-infected organoids as well
as the Wnt-independent organoids generated in the previous
experiment. After dissociation, 10,000 single cells were re-seeded
from each condition, and the number of organoids formed was
quantified. Cells that were obtained from the WT pks+ E. coli-
infected condition had a higher organoid-forming capacity
compared to those that were non-infected or infected with the
ΔclbR mutant. However, the highest capacity was observed for
cells derived from the Wnt-independent organoids (Fig. 2d, e).
The Wnt-independent organoids were also found to grow for a
longer period than non-infected organoids, which could only be
maintained for about 20 passages. All biological replicates of
Wnt-independent organoids were maintained in culture for more
than 1 year, with one replicate maintained for over 2.5 years, and
none showed any sign of slowed growth when the culture was
discontinued. The passaging ratio was also higher for the Wnt-
independent organoids, reflecting their increased growth capacity
(Fig. 2f). Accordingly, immunolabeling of organoids 7 days after
passaging showed that Wnt-independent organoids had a higher
percentage of Ki67-positive cells when compared to non-infected
organoids (Fig. 2g and h). In summary, Wnt-independent colon
organoids generated by the action of colibactin had increased
organoid-forming capacity, an increased number of proliferating
cells, and potentially unlimited expansion capacity in culture.
Wnt-independent organoids show upregulated Wnt/β-catenin
signaling and downregulation of differentiation genes. Next,
we determined if stem cell-associated pathways were upregulated
Fig. 1 pks+ E. coli cause DNA damage, megalocytosis, and formation of multinucleated cells in primary colon epithelial cell cultures.
a Immunofluorescence staining of Caco-2 cells showing γH2AX (white). Phalloidin (red) stains for actin filaments and Hoechst (blue) stains for DNA.
Caco-2 cells infected with pks+WT E. coli are γH2AX-positive, display megalocytosis, and are multinucleated. Less γH2AX is detected in cells infected with
the mutant strain (E. coli ΔclbR) defective for colibactin synthesis. Image representative of three independent replicates. Scale bars: 10 μm. b Epithelial cells
from colon organoids are sheared and seeded on collagen-coated polycarbonate filter inserts. The cells attach and form a columnar polarized monolayer.
Secreted mucus accumulates on the apical side. c Top: Cross-section of the polarized monolayer showing expression of colonic mucus MUC2 (red) and β-
catenin (green). Hoechst (blue) stains for DNA. Bottom: Cross-section of the polarized monolayer showing expression of basolateral E-cadherin (green)
and the proliferation marker Ki67 (red). Hoechst (blue) stains for DNA. Image representative of three independent replicates. Scale bars: 10 μm.
d tdTomato (red) expressing colonic monolayer immunostained for γH2AX (white); Hoechst (blue) stains for DNA. Megalocytosis, multinucleated cells,
and γH2AX-positive cells are observed in monolayer infected with pks+WT E. coli. Image representative of three independent replicates. Scale bars: 10 μm.
e Murine colon organoids expressing membrane tdTomato (red) immunostained for γH2AX (white); Hoechst (blue) was used to stain for DNA. Cells in
colon organoids are γH2AX-positive only when infected with the pks+ WT E. coli. Image representative of three independent replicates. Scale bars: 10 μm.
f CFUs per 100,000 cells of murine colon organoids from three independent replicates. Data represent mean ± SD, p < 0.05, as calculated by two-sided
unpaired Student’s t-test. g Comet assay of murine colon organoid cells (each data point represents the mean of >80 cells) from three independent
replicates shows more DNA damage in pks+ WT E. coli-infected cells, which is comparable to etoposide, the positive control. Data represent mean ± SD,
p < 0.05, as calculated by one-way ANOVA and Tukey’s test. Source data are provided as a Source Data file.
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in Wnt-independent organoids. We performed RNA sequencing
of non-infected and Wnt-independent organoids. All cultures
were grown in a complete 3D medium for 5 days, followed by
growth in medium without Wnt and CHIR99021 for 3 days.
GSEA revealed a significant enrichment of Lgr5 signature genes31
in Wnt-independent organoids when compared to non-infected
organoids (Fig. 3a). All three replicates of Wnt-independent
organoids expressed higher levels of Wnt target genes when
compared to the respective non-infected cultures (Fig. 3b). We
performed RT-qPCR for Lgr5 (the classic intestinal stem cell
marker), Lef-1, Fzd7, and β-catenin (Ctnnb1) and found higher






























































































































































Fig. 2 Wnt-independent growth of organoids after infection with pks+ E. coli. a Organoids formed after seeding 50,000 non-infected, pks+ WT E. coli-
infected, and E. coli ΔclbR-infected cells from three independent replicates. Data represent mean ± SD, p < 0.05, as calculated by two-sided unpaired
Student’s t-test. b Scheme describing the infection of organoids. c Organoids grow without the addition of Wnt and CHIR99021 to the medium for the pks+
WT E. coli-infected condition, but not for the non-infected or E. coli ΔclbR-infected conditions. Image representative of four independent replicates. Scale
bars: 1 mm. d Organoids formed after seeding 10,000 cells in each condition. Image representative of three independent replicates. Scale bars: 1 mm.
e Quantification of the number of organoids formed after seeding 10,000 cells in each condition from three replicates. Data represent mean ± SD, p < 0.05,
as calculated by two-sided unpaired Student’s t-test. f Wnt-independent organoids have a higher splitting ratio and grow indefinitely when compared to
non-infected organoids. Graph representative of four independent replicates. g Immunofluorescence staining for Ki67 (red) in non-infected organoids and
Wnt-independent organoids. Hoechst (blue) stains for DNA. Image representative of three independent replicates. Scale bars: 100 μm. h Quantification of
the percentage of Ki67-positive cells from three replicates. Data represent mean ± SD, p < 0.05, as calculated by two-sided unpaired Student’s t-test. NI=
non-infected and WI=Wnt-independent. Source data are provided as a Source Data file.
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(cultured in −Wnt medium) when compared to non-infected
organoids (cultured in +Wnt medium) (Fig. 3c). Immunostain-
ing for β-catenin showed the presence of nuclear β-catenin in
Wnt-independent organoids in the presence or absence of Wnt,
indicating active Wnt/β-catenin signaling. Non-infected orga-
noids kept in the absence of Wnt for 24 h showed absence of
nuclear β-catenin in several nuclei (Fig. 3d). Furthermore, gene
sets implicated in Wnt signaling that are upregulated or down-
regulated due to stabilization of β-catenin in intestinal orga-
noids32 showed a significant positive and negative enrichment,
respectively, in Wnt-independent organoids when compared to
non-infected organoids (Fig. 3e). The Wnt-independent orga-
noids rely on endogenous Wnt production because treatment
with a porcupine inhibitor (IWP-2) led to inhibition of their
growth, which could be rescued by exogenous Wnt (Supple-
mentary Fig. 5a). This indicated that these organoids showed a
higher sensitivity to endogenous Wnt. We explored the
expression pattern of selected genes encoding for Wnt receptors
and found a higher expression of Lrp6, Fzd7, and Fzd10, which
could be responsible for the increased sensitivity to endogenous
Wnt signals (Fig. 3b, c and Supplementary Fig. 5b).
Upregulated Wnt signaling in intestinal organoids has
previously been shown to cause cells to adopt a proliferative
progenitor phenotype, which results in a shift from the
asymmetric crypt-villus architecture to a spheroid, cyst-like
morphology devoid of differentiated cell types33. Accordingly,
we noticed that Wnt-independent organoids formed spheroid,
cyst-like organoids, unlike the non-infected condition (Fig. 3f).
To quantify this, all conditions were kept in complete 3D medium
for 7 days, and any organoid showing a budding structure was
scored as a differentiated organoid (Fig. 3g). Further, GSEA
revealed an upregulation of gene sets implicated in proliferation
and downregulation of gene sets involved in fatty acid
metabolism, which are active in differentiated colonocytes
Non-infected organoids Wnt-independent organoids
+Wnt medium






















Lgr5 SC Signature Munoz
FDR=0.029
CTNNB1 stab up Riemer
FDR=0.029















































































































































































ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-21162-y
6 NATURE COMMUNICATIONS |         (2021) 12:1003 | https://doi.org/10.1038/s41467-021-21162-y | www.nature.com/naturecommunications
(Fig. 3h). In addition, the enterocyte-specific differentiation genes
carbonic anhydrase 4 (Car4) and aquaporin 8 (Aqp8) were
downregulated in Wnt-independent organoids (Fig. 3i). Thus,
infection-induced Wnt-independence of organoids was accom-
panied by a proliferative cell phenotype and impaired
differentiation.
Wnt-independent organoids have major chromosomal aber-
rations and high mutational load. To determine whether the
alterations induced by colibactin are linked to mutations, we
generated clonal and pooled cultures from non-infected and
Wnt-independent organoids and performed whole-genome
(WGS) and whole-exome sequencing (WXS) on cells obtained
from two replicates. We identified a higher number of clonal
(allelic proportion >25%) single nucleotide variants (SNV),
insertion and deletion (indel) mutations, and detected rearran-
gement breakpoints (rearrangements) in Wnt-independent
organoids compared to non-infected controls. Approximately
875 million and 650 million base pairs were affected by copy
number variations (CNV) in clones generated from Wnt-
independent organoids from replicate 1 and replicate 2, respec-
tively (Fig. 4a). However, many of the identified mutations were
shared between clones from the same mouse (genomic losses on
chromosomes 4, 5, and 13 in replicate 1 and chromosomes 2, 4, 5,
10, 13, 17, and 19 in replicate 2), indicating that they may have
originated from the same mutated cell (Supplementary Fig. 6a).
Thus, the Wnt-independent cells show features of CIN with
CNV, including predominant losses of whole chromosomes or
chromosome arms (Fig. 4b), in agreement with chromosomal
aberrations induced during mitosis16. Subclonal changes such as
additional breaks, genomic gains, and genomic losses indicate
ongoing instability, including chromosome 14 of replicate 2,
which exhibited multiple breakpoints and CNV in close proxi-
mity with pure intrachromosomal relocations, which may be a
sign of chromothripsis34. Over 3600 genes were found to be
affected, mostly by CNV, but to a lesser extent by SNV or by both
SNV and CNV. Copy-number imbalances affected about 3500
expressed protein-coding genes in each sample, while only about
10–20 genes showed protein changes due to single nucleotide
substitutions or small indels (Fig. 4c). Among them were genes
known to be involved in Wnt signaling, in the p53 pathway, and
known cancer drivers (Fig. 4d). We did not identify CNV or
known driver mutations in the mouse homologs of the key Wnt-
signaling genes Apc or Ctnnb1. Instead, Wnt-independent clones
showed copy number changes in a number of additional genes
frequently mutated across cancers35 or specifically in colorectal
carcinoma4 (Supplementary Fig. 6b). Both replicates had a het-
erozygous loss of AT-rich interactive domain-containing protein
1 A (Arid1a), which is mutated in several types of cancer36.
Arid1a has been shown to act as a tumor suppressor in the mouse
colon by enhancer-mediated gene regulation37, and in ovarian
cancer ARID1A mutation has been shown to functionally inac-
tivate TP5338. In both replicates of exome sequencing, there was a
heterozygous loss of the micro-RNA-34a (miR-34a) gene. miR-
34a expression is induced by p53 and is known to play important
roles in the downregulation of the Wnt pathway and in tumor
suppression39,40. In one of our replicates, there was a hetero-
zygous loss of cyclin-dependent kinase inhibitor 1a (Cdkn1a/p21)
gene, while the other one showed a loss of cyclin-dependent kinase
inhibitor 1b (Cdkn1b), both of which are involved in cell cycle arrest.
Cdkn1a is a target of p53 and acts downstream to inhibit cellular
proliferation. In both replicates, there was also a heterozygous loss of
cyclin-dependent kinase inhibitor 2a (Cdkn2a), known to act
upstream of p53. One replicate had gain-of-function of cyclin-
dependent kinase 2 (Cdk2) and cyclin-dependent kinase 4 (Cdk4),
genes involved in cell cycle progression that are negatively regulated
by p53. The Wnt and p53 pathways are complex regulatory net-
works, therefore it is not unlikely that a mutation or a combination
of mutations induced by colibactin disrupted these critical pathways,
which are important for cellular proliferation and tumorigenesis.
A mutational signature of colibactin action on DNA has
recently been identified23,24. We tested if we could identify
hallmarks of this signature in our Wnt-independent clones. We
neither identified the previously described increase in T > N
substitutions at ATA, ATT, and TTT24 (Supplementary Fig. 6c)
nor a relevant increase in small indels at A:T homopolymers
(Supplementary Fig. 6d). We also did not observe an enrichment
of structural variant breakpoints at the reported AAWWTT
motif23 (Supplementary Fig. 6e). Based on previous data24, only a
small number of colibactin-associated SNV and small indels are
expected in our experimental setting (i.e., about 4 SNV and 1
indel after 3 h infection compared to about 500 additional single
Fig. 3 Wnt-independent organoids show upregulated Wnt/β-catenin signaling and downregulation of differentiation genes. a Global comparison using
gene set enrichment analysis between intestinal stem cell genes31, and RNA sequencing results from three replicates. Genes are ordered according to their
differential expression in Wnt-independent vs. non-infected samples from left to right. Intestinal stem cell genes are marked by black bars below the plot.
Plot line shows the running enrichment score. b Wnt-independent organoids have a higher expression of Wnt target genes when compared to respective
non-infected conditions. Data are mean-centered and averaged expression values for each replicate (n= 3) and condition. c RT-qPCR data showing
expression of Lgr5, Lef1, Fzd7, and β-catenin (Ctnnb1) relative to Gapdh from three independent replicates. Data represent mean ± SD, p < 0.05, as calculated
by two-sided unpaired Student’s t-test. NI= non-infected and WI=Wnt-independent. d Immunostaining for β-catenin (green) in non-infected and Wnt-
independent organoids. Upon removal of Wnt from the medium for 24 h, non-infected organoids show the absence of nuclear β-catenin (marked by the
yellow arrow). DAPI (blue) stains for DNA. Image representative of three independent replicates. Scale bars: 10 μm. e Global comparison using gene set
enrichment analysis between genes upregulated and downregulated during activated β-catenin signaling32, and RNA sequencing results from three
replicates. Genes are ordered according to their differential expression in Wnt-independent vs. non-infected samples from left to right. Genes are marked
by black bars below the plot. Plot line shows the running enrichment score. f Immunofluorescence image of a single organoid on day 7 after seeding. Image
representative of three independent replicates. Scale bars: 100 μm. g Bar graph of the percentage of differentiated organoids from three replicates on day 7
after seeding. >90 organoids counted per condition for each replicate. Data represent mean ± SD, p < 0.05, as calculated by two-sided unpaired Student’s t-
test. NI= non-infected and WI=Wnt-independent. h Hallmark genes associated with mitosis (Hallmark G2M checkpoint, Hallmark E2F targets, and
Hallmark mitotic spindle gene sets) are enriched among upregulated genes, and hallmark genes associated with differentiation (Hallmark peroxisome,
Hallmark fatty acid metabolism, and Hallmark oxidative phosphorylation gene sets) are enriched among downregulated genes in all three replicates of
Wnt-independent organoids when compared to non-infected organoids. Normalized enrichment score (NES) for a given gene set is the enrichment score
normalized to mean of the enrichment scores for all data set permutations. Results are significant (FDR < 20%), except for Hallmark oxidative
phosphorylation of replicate 2. i RT-qPCR data showing expression of Car4 and Aqp8 relative to Gapdh from three independent replicates. Data represent
mean ± SD, p < 0.05, as calculated by two-sided unpaired Student’s t-test. NI= non-infected and WI=Wnt-independent. Source data are provided as a
Source Data file.
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Fig. 4 Wnt-independent organoids have major chromosomal aberrations and high mutational load. a The number of detected insertions and deletions
(indels), somatic single nucleotide variants (SNV), and detected rearrangement breakpoints (Rearrangements) in Wnt-independent (WI) and non-infected
(NI) organoids in two independent replicates from whole-genome sequencing (WGS). Genome length affected by copy number variations (CNV) for Wnt-
independent (WI) and non-infected (NI) organoids in two independent replicates from WGS. Each condition was compared to the pool of non-infected
organoids of that respective experiment. b Circos plots showing CNV, SNV, indels, structural variants, and mutated genes in the Wnt-independent
organoids for replicates 1 and 2 from WGS. Each section represents chromosomes 1–19, chromosome X, and chromosome Y. The central part shows
aberrant genomic fusions in the Wnt-independent condition. The two innermost circles (WI and NI) represent CNV in non-infected (NI) organoid clones
and Wnt-independent (WI) organoid clones, respectively. The blue (genomic loss) and red (genomic gain) regions represent CNV. All losses of
chromosomal regions are heterozygous. Each condition was compared to all the non-infected organoids of that respective replicate. A rainfall plot (red
dots) shows the SNV and indel variations and the distances between them on the y-axis only for the Wnt-independent condition. The green, orange, and
black lines depict positions of mutated Wnt pathway genes, known cancer driver genes, and p53 pathway genes, respectively, in the Wnt-independent
condition. c The number of genes affected in each sample by CNV and/or SNV analyzed by WGS. For CNV, only genes expressed in non-infected controls
were considered. For SNV, only mutations that change the amino acid sequence are shown. d Mutational status of genes of the Wnt pathway that are
frequently affected in CRC, genes of the micro-RNA-34 family, and Trp53. Blue, genomic loss; red, genomic gain. Source data are provided as a Source
Data file.
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base substitutions and 150 indels after 5 repetitions of 3 days of
infection24, assuming a uniform rate of mutations over time). On
the other hand, chromosomal aberrations have been observed 24
h after a 4 h exposure to colibactin-producing E. coli16. Indeed,
our data indicate that colibactin-induced cross-links might lead to
genomic instability even after short contact, without evidence of a
mutational signature, which most likely requires long-term or
repetitive exposure to colibactin.
These sequencing results, therefore, show the genomic lesions
in primary colon cells resulting from a single 3 h infection with
pks+ E. coli. We conclude that Wnt-independent organoids show
hallmarks of CIN and an increased mutational load affecting large
numbers of genes, some of which are tightly linked to the
p53 signaling pathway, which individually or in combination
could have led to the development of niche independence.
The Trp53/miR-34 axis is disrupted in the Wnt-independent
organoids. As we noticed that several genes involved in
p53 signaling were affected in the Wnt-independent organoids
upon exposure to pks+ WT E. coli, we immunolabeled the
organoids for p53 and observed the presence of nuclear p53 in
several cells (Fig. 5a). We next checked the sensitivity of Wnt-
independent organoids to Nutlin-3a, which activates the p53
pathway and acts as an apoptosis inducer. While non-infected
organoids did not grow when Nutlin-3a was added to the med-
ium, the Wnt-independent organoids continued to grow (Fig. 5b),
indicating a defect downstream of p53.
To examine if there is a connection between Wnt-
independence and disruption of the p53 pathway, we first tested
whether loss of the Trp53 gene results in organoids that grow in
the absence of Wnt. For this, we generated organoids from the
colon of Trp53flox/flox mice. The Trp53 gene was floxed out by the
transduction of organoids with an adeno-associated virus
encoding the Cre recombinase (AAV-Cre). To select cells with
a successful knockout, the organoids were grown in the presence
of Nutlin-3a. The depletion of p53 was further verified by western
blot analysis. Non-transduced organoids were grown for 6 days
and then kept in the presence of Nutlin-3a for 2 days to stabilize
the p53 protein, while transduced organoids were cultured with
Nutlin-3a for 8 days, confirming the loss of Trp53 (Fig. 5c). The
Trp53 KO organoids continued to grow when Wnt and
CHIR99021 were withdrawn from the medium, while non-
transduced organoids grew neither in the presence of Nutlin-3a
nor in the absence of Wnt (Fig. 5d). Therefore, loss of Trp53 is
sufficient to confer independence from extrinsic Wnt signals.
As we did not detect a mutation in the Trp53 gene in the
sequencing results, and as p53 was found in the nuclei, we
hypothesized that Wnt-independence could be driven by an
altered effector downstream of p53, and investigated if the loss of
the miR-34a gene could have led to extrinsic Wnt-independence
in the organoids. miR-34a is expressed at higher levels than miR-
34b/c, with the exception of the lung, in which miR-34b/c is highly
expressed41. RT-qPCR for pri-miR-34 showed downregulation of
pri-miR-34a and pri-miR-34b/c in Wnt-independent organoids
when compared to non-infected organoids (Fig. 5e). Lower
expression of mature miR-34a and miR-34b, but not miR-34c,
was observed in Wnt-independent organoids (Fig. 5f). It has
previously been shown that some epithelial-mesenchymal transi-
tion (EMT)-inducing transcription factors can bind to E-boxes of
miR-34a and miR-34b/c promoters, thereby repressing miR-34a
and miR-34b/c expression42. GSEA of the Wnt-independent
organoids also showed an enrichment of EMT-related genes
(Supplementary Fig. 7a).
To explore the function of miR-34, we generated colon
organoids from miR-34a, miR-34b/c, and mir-34a/b/c KO mice,
and found an increased expression of Lgr5 and β-catenin
(Ctnnb1) in miR-34a KO organoids, which was even more
pronounced in miR-34a/b/c KO mouse-derived organoids. miR-
34a KO and miR-34a/b/c KO organoids also showed increased
expression of Lrp6 and Fzd7, similar to the Wnt-independent
organoids generated upon infection (Supplementary Fig. 7b).
Furthermore, we observed that colon organoids generated from
miR-34a/b/c KO mice were able to grow in the absence of Wnt
and CHIR99021, whereas depletion of miR-34a alone was
insufficient to maintain Wnt-independent long-term cultures
(Fig. 5g). Thus, we conclude that the heterozygous loss of the
miR-34a gene and the downregulation of miR-34a/b expression
upon infection could together account for the observed
phenotypic changes in colon organoids.
Discussion
We demonstrate here the transformation of normal, healthy
primary epithelial cells to a premalignant state upon short-term
exposure in vitro to a bacterium that is a frequent constituent of
the human intestinal microbiota. Specifically, infection of colon
organoid cells with colibactin-producing pks+ E. coli led to the
generation of mutant organoids that grew independently of Wnt.
Aberrant Wnt signaling is observed in over 94% of CRC cases4.
Also, niche factors have been shown to become dispensable for
cancer organoids2,3. By selecting for Wnt-independence, we
enriched for organoids that were mutated after exposure to pks+
E. coli out of a pool of non-affected or differently mutated cells.
Importantly, to capture these clones, short-term infection with
colibactin-producing E. coli was sufficient, and no Wnt-
independent organoids were generated by infecting with an iso-
genic mutant defective for colibactin synthesis. This observation
suggests a ‘hit-and-run’ mechanism for the transformation of
normal primary cells to Wnt-independence upon contact with
pks+ E. coli.
The Wnt-independent organoids generated upon infection
exhibited accelerated growth, increased organoid formation, and
prolonged expandability in culture. Additional signs of transfor-
mation included increased expression of Wnt target genes, loss of
differentiation markers, and metabolic resemblance of these
organoids to undifferentiated cells. Our extensive sequence ana-
lysis of Wnt-independent organoids generated by independently
infected colon organoid lines revealed a plethora of mutations but
none of them directly affected classical Wnt-signaling genes, such
as Apc, which is often mutated in human colon cancer4. Never-
theless, the Wnt pathway was mostly affected indirectly by other
mutational changes, e.g., in regulatory genes also frequently seen
in human CRC. Likewise, miR-34 members that exhibit defects in
a subset of human cancers were heterozygously deleted and found
to be downregulated in both replicates. miR-34a is known to be
activated by p53 and downregulates Wnt signaling39. miR-34a was
found to be silenced in approximately 75% and miR-34b/c in
approximately 99% of sporadic CRC tumor samples43,44. In
ApcMin/+ mice, miR-34a/b/c have been shown to suppress ade-
noma formation45. Ectopic expression of miR-34 induces cell cycle
arrest in primary and tumor-derived cell lines46. miR-34a is also
known to contribute to p53-mediated apoptosis and EMT
suppression42,47. Moreover, miR-34a loss suppresses asymmetric
division and increases Lgr5+ intestinal stem cell proliferation
under inflammatory stress48,49. Interestingly, our infection-
transformed organoids exhibited increased nuclear localization
of p53 and resistance to Nutlin-3a. Heterozygouos loss of miR34-a
and downregulation of miR-34a/b expression in the Wnt-
independent organoids could potentially contribute to Nutlin-3a
resistance. Further, our results showed that Trp53 KO and miR-
34a/b/c KO colon organoids can grow Wnt-independently, in
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concordance with previous work showing a functional overlap
between these pathways39. TP53 mutations are known to occur
early in a subset of CRC, such as colitis-associated cancer7. Given
the diversity of mutational patterns conferring Wnt-indepen-
dence, considered as the hallmark of colon cancer initiation, it
seems plausible that mutations other than the APC mutations
frequently seen in advanced stages of cancer may arise at very
early stages in the sequence of transforming events, yet have
escaped attention. Mutations affecting miR-34a, as generated here
by pks+ E. coli, may be such an example. Therefore, our data
strongly suggest that disruption of the p53/miR-34 axis, along with
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Fig. 5 The Trp53/miR-34 axis is disrupted in the Wnt-independent organoids. a Organoids immunostained for p53 (green) and β-catenin (red). DAPI
(blue) was used to stain for DNA. Image representative of three independent replicates. Scale bars: 10 μm. b Wnt-independent organoids grow in the
presence of Nutlin-3a in the medium. Image representative of three independent replicates. Scale bars: 1 mm. c Western blot to verify knockout of Trp53 in
organoids after transduction with AAV-Cre. Image representative of two independent replicates. d Organoids from Trp53flox/flox mice grow in the presence
of Nutlin-3a and absence of Wnt and CHIR99021 only when transduced with AAV-Cre. Image representative of two independent replicates. Scale bars:
100 μm. e RT-qPCR data showing expression of pri-miR-34 relative to TUBB from three independent replicates. Data represent mean ± SD, p < 0.05, as
calculated by two-sided unpaired Student’s t-test. NI= non-infected and WI=Wnt-independent. f RT-qPCR data showing expression of mature miR-34
relative to U6 from three independent replicates. Data represent mean ± SD, p < 0.05, as calculated by two-sided unpaired Student’s t-test. NI= non-
infected and WI=Wnt-independent. g Organoids from miR-34a KO mice do not grow in the absence of Wnt and CHIR99021, whereas organoids from
miR-34a/b/c KO mice do grow in the absence of Wnt and CHIR99021. Image representative of two independent replicates. Scale bars: 1 mm. Source data
are provided as a Source Data file.
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Wnt-independent phenotype in colon organoids. Such mutant
cells displaying increased pro-survival signaling may possess a
competitive growth advantage over normal cells and grow out to
premalignant lesions, including polyps, in affected patients.
The mutational changes in the Wnt-independent organoids
included SNV, but mainly CNV. Surprisingly, in these short-term
infected organoids we failed to identify the specific mutational
signature that we and others have recently shown to be induced
by colibactin23,24. Notably, these previous studies derived from
different experimental settings that aimed for the induction of
high DNA damage or mutational burdens, yet did not explore the
transforming potential of colibactin. In contrast, here, we exposed
primary colon cells to pks+ E. coli only for very short times,
reminiscent of the conditions in the dynamic process of crypt
regeneration in the colon. This short exposure to colibactin suf-
ficed to transform cells, suggesting that mutational changes dis-
tinct from the accretion of the recently published colibactin
signature were involved.
Obviously, the characteristic colibactin signature is the result of
an intricate damage and repair process ensuring minimal localized
damage. Any failures to properly resolve the colibactin-induced
cross-links, however, would lead to rather crude types of damage,
such as severe chromosomal aberrations, in case mitosis pro-
ceeds50. This could explain the occurrence of multinucleated cells
and aneuploidy as observed here, consistent with the occurrence
of CIN, previously seen in intestinal epithelial cells after exposure
to pks+ E. coli16. Resulting CNV have been identified as a pre-
dominant characteristic of the majority (~85%) of sporadic
CRCs51, and are observed at early stages of the malignancy,
facilitating cancer progression52. While in most cases mitotic
stress due to aberrant or damaged chromosomes leads to mitotic
arrest or cell death, some cells might evade this fate by mitotic
slippage53. Accordingly, the occurrence of CIN and CNV fol-
lowing colibactin treatment is thought to be the result of ineffi-
cient local resolution of cross-links at the damaged sites, rendering
cells prone to transformation, e.g., Wnt-independent growth.
The previous identification of the colibactin mutational
signature23,24 in colon cancer genomes established a clear link
between colibactin and the etiology of certain CRCs. The less-
defined chromosomal aberrations resulting from improper repair
of colibactin-induced damage, however, might play a prevailing
role in cell transformation. Accordingly, the cancer-inducing
potential of colibactin-producing bacteria might be higher than
the frequency of the colibactin mutational signature suggests.
Notably, the specific colibactin signature is found only in 2.4–10%
of patients with CRC23,24, while colibactin-producing E. coli are
found in 67% of CRC patients17.
We also observed variability in the genotoxicity between
commensal E. coli strains. E. coli M1/5 is slightly more genotoxic
than E. coli Nissle 1917, which is commonly used as a probiotic54.
While we demonstrate that E. coli Nissle 1917 also causes DSBs
and cross-links DNA, its damaging activity appears to be below
the threshold, incapable of transforming cells to Wnt-
independence in our assay. However, based on results in vitro,
it is difficult to estimate the exact relative genotoxic activity
in vivo, since it is subject to regulation by various factors, most
prominently the availability of iron in the microenvironment of
the infection at the pathogen–host cell interface55,56. While
additional and as yet uncertain modulatory factors of colibactin
expression, production, and delivery may play a role in terms of
DNA damage-induction and cancer promotion, at this point it
would appear prudent to view the use of colibactin-producing
bacteria as probiotics with caution.
Taken together, our data demonstrate the transforming
potential of pks+ E. coli in vitro and recapitulate the early stages
of malignant transformation through infection of colon
organoids. In particular, it highlights the relevance of CNV
mutations leading to Wnt-independence as early drivers in colon
cancer. While the colibactin mutational signature provides a clear
link between colibactin action and colon carcinogenesis, coli-
bactin’s transforming activity is likely higher than what can be
estimated from the occurrence of that signature.
Methods
Bacterial strains, cell line, and mouse strains. The WT E. coli B2 pks+ M 1/5
human fecal isolate strain was used for the infections. The isogenic mutant strain
used has clbR gene deleted in the pks island, which substantially hinders the ability
of the bacterium to synthesize colibactin26. The WT and the mutant E. coli ΔclbR
strain have a rpsL K42R mutation, which renders the strain streptomycin-resistant.
For Supplementary Fig. 4, E. coli Nissle 1917 and E. coli Nissle 1917 ΔclbB strains
were used. The cell line used was human colorectal adenocarcinoma cells Caco-2
(ATCC HTB-37). The cells were cultured in Dulbecco’s Modified Eagle Medium
(DMEM, Gibco) +20% fetal calf serum (FCS, Biochrom). The mouse strains used
were mTmG (JAX stock #007676)57, Trp53flox/flox (Jackson stock #008462)58, miR-
34a KO45, miR-34b/c KO45, and miR-34a/b/c KO45. All procedures involving
animals were approved by the institutional and legal authorities at the Max Planck
Institute for Infection Biology (Landesamt für Gesundheit und Soziales, Berlin). All
animals were maintained in autoclaved microisolator cages and provided with
sterile drinking water and chow ad libitum. Male 4–12 week old mice were used for
this study.
Generation of mutant E. coli ΔclbR. The deletion of clbR in E. coli strain M1/5 has
been generated by lambda red-mediated recombineering59. A npt kanamycin




CCTCCTTAGTTCC) and used for replacement of the clbRA genes in E. coli strain
M1/5 (pKD46). The resulting mutant E. coli M1/5 ΔclbRA (pKD46) was then
transformed with a PCR product amplified from pKD3-ΔclbR1 (primer pair
ATATGAAAATCAATATTATCGACGGCTCAGAAGTGTCTAGATTA
TCCGTGGCGATCATATGAATATCCTCCTTAGTTCC/ACCGTTGTATCGTA
AATTCCTC). The PCR product included 132 bp of the clbR upstream region, the
complete clbA gene, a cat cassette, an FRT site, and 55 nucleotides of the clbA
downstream sequence. The PCR product was chromosomally inserted via
recombination of two FRT site sequences upstream of npt and downstream of cat.
The chromosomal npt and cat cassettes were then removed by transformation of
this strain with pCP20 encoding the FLP recombinase60.
Murine colon organoid culture, passaging, and cloning. The mice were sacri-
ficed, and the colons isolated. The colons were cut longitudinally and cleaned with
1X phosphate-buffered saline (PBS) (Gibco), cut into small pieces, and the tissue
fragments incubated in a cold chelating buffer (distilled water with 2 mM EDTA,
5.6 mM Na2HPO4, 8 mM KH2PO4, 96.2 mM NaCl, 1.6 mM KCl, 43.4 mM sucrose,
54.9 mM D-sorbitol, 0.5 mM DL-dithiothreitol) for 30 min at 4 °C on a roller
mixer. The tube was vigorously shaken to resuspend tissue fragments and to isolate
the colon crypts. The tissue fragments were allowed to settle by gravity, and the
supernatant containing the crypts was removed and centrifuged at 300g for 5 min
at 4 °C. The pellet was resuspended in Advanced DMEM/F-12 (Gibco) containing
10% heat-inactivated FCS and centrifuged at 300g for 5 min at 4 °C. The pellet was
resuspended in 1 ml Advanced DMEM/F-12 containing 10% FCS and the number
of crypts were counted using a hemocytometer. A total of 500 crypts were resus-
pended and seeded in a 40 µl Matrigel (Corning) drop in a 24-well plate. The
Matrigel was polymerized at 37 °C for 10 min and then supplemented with 500 μl
medium: Advanced DMEM/F-12 supplemented with 10 mM HEPES (Gibco), 1%
Glutamax (Gibco), 50% Wnt-3A conditioned medium, 25% R-spondin-1 condi-
tioned medium, 100 U/ml penicillin/streptomycin (Gibco), 1X N2 (Gibco), 1X B27
(Gibco), 1.25 mM N-acetylcysteine (Sigma), 50 ng/ml murine epidermal growth
factor (mEGF) (Invitrogen), 100 ng/ml murine noggin (Peprotech), 0.5 μM A-83-
01 (Sigma), 3 μM CHIR99021 (Stemgent), and 9 μM Y-27632 dihydrochloride
(Sigma). The organoids were incubated at 37 °C, 5% CO2 in a humidified incu-
bator. To the medium, 10 μg/ml metronidazole (Sigma) and 10 μg/ml ciprofloxacin
(Bayer) were added additionally for the first 3 days. The medium was changed
twice a week. Every 7 days, the organoids were passaged 1:2–1:5 by mechanically
disrupting organoids and Matrigel with cold 1X PBS before transferring into a 15
ml falcon tube. After centrifugation at 300g for 5 min at 4 °C, the pellet was treated
with TrypLE (Gibco) and incubated for 5 min at 37 °C, followed by dissociation
using a flame-polished glass Pasteur pipette. The dissociated organoids were
washed with 10 ml Advanced DMEM/F-12 containing 10% FCS and centrifuged at
300g for 5 min at 4 °C. The pellet was resuspended in 1 ml advanced DMEM/F-12
containing 10% FCS, and the number of cells counted using a hemocytometer. The
required number of cells were resuspended and seeded per 40 μl Matrigel drop in a
24-well plate. The Matrigel was polymerized for 10 min at 37 °C. Each well was
supplemented with 500 μl of medium and incubated at 37 °C, 5% CO2 in a
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humidified incubator. For generating clones, a single organoid was isolated and
passaged to obtain the required number of cells. The concentration of cisplatin
(Sigma) was 50 μM for monolayers and 10 μM for organoids. Etoposide (Sigma)
was used at 50 μM concentration, IWP-2 (Sigma) was used at 5 μM concentration,
and Nutlin-3a (Sigma) was used at 10 μM concentration.
Human colon organoid culture. The human colon biopsies and tissue samples
were received from surgeries performed at the Charité University Medicine, with
prior approval of the ethics committee of the Charité University Medicine, Berlin
(EA1/300/15) and informed consent was obtained from all donors. The biopsies
were kept in ChillProtec medium (Biochrom) at 4 °C, and the isolation of crypts for
organoid culture was carried out within 2–3 h after surgery. The tissue was washed
with 1X PBS and cut into small pieces, and the tissue fragments were incubated in a
1X cold chelating buffer for 30 min at 4 °C on a roller mixer. The remaining steps
were the same as for the murine colon organoid culture. The human colon orga-
noid medium contained Advanced DMEM/F-12 supplemented with 10 mM
HEPES (Gibco), 1% Glutamax (Gibco), 38 ng/ml surrogate Wnt (U-Protein
Express BV), 25% R-spondin-1 conditioned medium, 100 U/ml penicillin/strep-
tomycin (Gibco), 1X N2 (Gibco), 1X B27 (Gibco), 1.25 mM N-acetylcysteine
(Sigma), 10 ng/ml human epidermal growth factor (hEGF) (Invitrogen), 100 ng/ml
human noggin (Peprotech), 0.5 μM A-83-01 (Sigma), 10 mM nicotinamide
(Sigma), 10 µM SB202190 (Sigma), 10 nM prostaglandin E2 (Tocris), and 9 μM Y-
27632 dihydrochloride (Sigma). The organoids were incubated at 37 °C, 5% CO2 in
a humidified incubator. For the first 3 days, 100 µg/ml Primocin (Invivogen) was
additionally added to the medium. The medium was changed twice a week. The
passaging protocol was the same as for the murine colon organoids.
Murine primary colon epithelial monolayer culture. Half a million cells derived
from murine colon organoids were resuspended in 200 µl of medium and seeded
into bovine collagen type I-coated (Gibco, 1 mg/ml) polycarbonate cell culture
inserts (Merck Millicell) placed in a 24-well plate. For monolayers, the medium
used for organoids was supplemented with 10% FCS. Outside the cell culture insert,
600 μl medium was added, and the plate was placed at 37 °C, 5% CO2 in a
humidified incubator. After 3 days, the medium from the cell culture inserts was
discarded. The medium outside the cell culture insert was changed twice each week.
In vitro infections. We determined that MOI of 20 and MOI of 5 was ideal for
Caco-2 and primary cells, respectively, to obtain DNA damage after a 3 h infection.
Higher MOIs caused very high or absolute cell death. Caco-2 cells were grown on
collagen-coated MatTek glass-bottom dishes. For infection of Caco-2 cells, the
medium was removed from 70% confluent cells. Infection medium (DMEM
containing 10% FCS and 10 mM HEPES) containing log-phase E. coli at MOI 20
was added to the cells. The cells were then kept for 3 h in an incubator at 37 °C. To
stop the infection, cell culture medium containing 200 μg/ml gentamicin (Sigma)
was added, and cells were incubated at 37 °C overnight. The next day, the medium
was changed to medium without gentamicin.
For infection of organoids, Matrigel was mechanically disrupted with infection
medium and transferred to a 15 ml Falcon tube. The organoids were broken up by
passing them through a flame-polished glass Pasteur pipette, so that both the basal
and apical sides were exposed to the bacteria. The organoids were centrifuged at
300g for 5 min at 4 °C in a 1.5 ml tube and resuspended in 250 μl of infection
medium. Log-phase E. coli at MOI 5 were added, and the tube incubated for 3 h at
37 °C. The organoids were centrifuged at 300g for 5 min at 4 °C and washed 2 times
with advanced DMEM/F-12 containing 10% FCS. The pellet was resuspended in
the required amount of Matrigel, and 40 μl drops added to each well in a 24-well
plate. The Matrigel was polymerized by placing at 37 °C for 10 min. Each well was
supplemented with 500 μl of medium containing 200 μg/ml gentamicin. The plate
was then incubated at 37 °C. The next day, the medium was changed to medium
without gentamicin.
Monolayers were infected by adding 250 μl of infection medium containing log-
phase E. coli at MOI 5 to the cell culture inserts and incubating at 37 °C for 3 h.
For obtaining CFUs, after 3 h of infection, the organoids were washed with 1X
PBS 5 times. The organoids were then treated with 0.2% saponin (Sigma) for 10
min at 37 °C to dissociate the attached bacteria. Serial dilutions were made and
plated on LB agar plates, and colonies were counted the following day.
Immunofluorescence. Caco-2 cells were grown on MatTek glass-bottom dishes
and washed with PBS and fixed with 3.7% paraformaldehyde (Sigma) for 1 h.
Organoids were mechanically disrupted and dissociated from Matrigel with cold
PBS, transferred into a glass tube and allowed to settle by gravity. The organoids
were then fixed with 3.7% paraformaldehyde for 1 h. Monolayers were washed with
PBS and fixed in 3.7% paraformaldehyde for 1 h. They were first embedded in
histogel (Thermo Scientific), followed by embedding in paraffin (Carl Roth). After
fixation, the tissue pieces, organoids, and monolayers were dehydrated (1 h incu-
bations in 70% EtOH, 80% EtOH, 90% EtOH, absolute EtOH, 100% isopropanol,
twice in xylene) and paraffinized, cut into 5 μm sections with a microtome, and
mounted on glass slides before dewaxing. For whole-mount staining of organoids,
they were fixed directly in the Matrigel by adding 500 μl of 3.7% paraformaldehyde
for half an hour at room temperature, then washed with 1X PBS before labeling.
For whole-mount staining of monolayers, the monolayers were washed with PBS
and fixed in 3.7% paraformaldehyde for 1 h, and then the filter was cut out and
stained. The staining was performed with the antibodies and dyes listed in Sup-
plementary Table 1. Primary antibodies were diluted in blocking solution (1% BSA,
2% FCS, and 0.1% Tween 20 in 1X PBS) and incubated overnight at 4 °C. Sec-
ondary antibodies were diluted in blocking solution, incubated for 45 min at room
temperature for paraffin sections, and overnight at 4 °C for whole-mount.
Mounting was done with Mowiol or Vectashield mounting medium (Vectorlabs,
Inc.). Images were acquired with a Leica TCS SP-8 confocal microscope and
processed using ImageJ 1.52.
Western Immunoblotting. For the western blots, organoids were harvested in 2X
Laemmli buffer, separated by 10% SDS-PAGE gels, transferred to a PVDF mem-
brane (PerkinElmer), blocked in TBS buffer supplemented with 0.1% Tween 20
(Merck) and 5% milk (AppliChem), and probed against primary antibodies p53
DO-1 (Santa Cruz Biotechnology, SC-126, 1:500 dilution) and β-actin (Sigma-
Aldrich, A5441, 1:10000 dilution) at 4 °C overnight. Membranes were probed with
matching secondary horseradish-peroxidase-conjugated antibodies (Amersham,
1:3,000) and detected with ECL reagent (PerkinElmer). An uncropped scan image
of the blot is provided in the Source Data file.
Real-Time qPCR. Organoids were released from Matrigel with cold 1X PBS and
pelleted by centrifugation (300g for 5 min at 4 °C), followed by RNA isolation using
the phenol-chloroform RNA extraction method. For primary miRNA, total RNA was
isolated using the miRNeasy mini kit (Qiagen), and for analysis, 1 μg of total RNA
per sample was used to generate cDNA using the Verso cDNA synthesis kit (Thermo
Fisher). qPCR was performed using a Power SYBR Green RNA-to-CT
1-Step Kit (Applied Biosystems). Reactions were performed in 25 μl containing
50–200 ng RNA, 10 μl SYBR Green mix, 0.16 μl RT mix, plus primers at 0.2 μM each.
Program: 30min at 48 °C; 10min at 95 °C; followed by 40 cycles of 15 s at 95 °C/60 s
at 60 °C. For analyses of mature miRNA expression, cDNA was
generated, and qPCR was performed using the miRCURY LNA RT kit (Qiagen), the
miRCURY LNA™ SYBR Green Master Mix (Exiqon), and the following commercially
available primers: mmu-miR-34a (Qiagen, YP00204486), mmu-miR-34b (Qiagen,
YP00204424), mmu-miR-34c (Qiagen, YP00205659), and the snRNA U6 (Exiqon,
203907). Primers used are listed in Supplementary Table 2. For each oligonucleotide
pair and RNA sample, the reaction was performed in triplicate. The data was ana-
lyzed using the delta-Cq method. The expression levels of the target genes were
normalized to the levels of glyceraldehyde-3-phosphate dehydrogenase (Gapdh) gene
expression in each individual sample. For primary miRNA, the expression was
normalized to TUBB, and for miRNA, the expression was normalized to U6.
DNA cross-linking assay. This method was adapted from Xue et al.61. Here, 1 ml
of overnight culture was centrifuged at 1600g for 3 min. The pellet was resuspended
in 20 ml M9-CAP medium and shaken at 200 rpm for 2 h at 37 °C. M9-CAP
medium contained M9 minimum media (Difco) supplemented with 0.4% glucose,
2 mM MgSO4, 0.1 mM CaCl2, 12.5 μg/ml chloramphenicol, and the following L-
amino acid mass composition (5 g/l total): 3.6% Arg, 21.1% Glu, 2.7% His, 5.6% Ile,
8.4% Leu, 7.5% Lys, 4.6% Phe, 4.2% Thr, 1.1% Trp, 6.1% Tyr, 5% Val, 4% Asn, 4%
Ala, 4% Met, 4% Gly, 4% Cys, and 4% Ser. At this time point, OD measured at
600 nm is 0.8 and there are 1 × 109 CFUs/ml. Serially diluted bacteria were added to
1.5 µg of pfdA8 plasmid DNA containing 3 µl of 50 mM EDTA and incubated for
90 min at 37 °C. Cleanup of DNA was done using QIAquick PCR Purification Kit
(Qiagen), and 300 ng of DNA samples were loaded in a 1% denaturing agarose gel
(1% agarose, 5% 1M NaCl, and 2% 50 mM EDTA water). The gel ran at 50 V for
2 h in running buffer (5% 1M NaOH and 0.2% 0.5 M EDTA in water). The DNA
was stained with SafeRed (Biotium), and the gel was imaged under UV light.
Neutral comet assay. The neutral comet assay was performed following infection,
etoposide (Sigma) treatment or cisplatin (Sigma) treatment of single cells derived
from organoids using the kit from Trevigen (4250-050-K), following the manu-
facturer’s protocol. Images were acquired using a fluorescent microscope (Leica
DMR). The percentage of DNA in the tail was quantified using the software
CometScore (TriTek 2.0).
Transduction. The organoids were dissociated with TrypLE and resuspended in
300 μl culture medium (without penicillin/streptomycin and N-acetylcysteine)
containing AAV-Cre adenovirus particles and 8 μg/ml polybrene (Sigma). Cells
were seeded in a 24-well plate coated with Matrigel. After overnight incubation, the
medium was removed, and a second layer of Matrigel was added and polymerized
as described above, before adding 500 μl culture medium. The culture was passaged
after 7 days.
RNA sequencing. RNA sequencing was performed at the Max Planck Genome
Centre, Cologne, using Illumina HiSeq3000. PolyA enrichment was applied to all
samples. For each sample of replicate 1, about 50 M single-end reads (150 bp) were
generated. For replicates 2 and 3, about 20M paired-end reads (2 × 150 bp) were
generated per sample. Gene expression was quantified by Salmon62, using pseudo-
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alignment of unaligned reads against transcript sequences from Gencode M12
(www.gencode.org). Gene quantification data generated by Salmon were further
processed in R using package DESeq263 to determine differentially expressed genes
between conditions and samples.
DNA sequencing. The sequencing of non-infected and Wnt-independent orga-
noids for both replicates was performed at passage 11 and passage 13 after
infection, respectively. All conditions were compared to all the non-infected
organoids of that respective replicate. For each condition, DNA was extracted from
approximately 1 million cells.
The exome sequencing was performed at the Max Planck Genome Centre,
Cologne, using Illumina HiSeq3000. Exome targets were captured using
SureSelectXT Mouse All Exon kit (Agilent Technologies) and sequenced using a
paired-end library protocol (2 × 150 bp) with a target coverage of 60-fold at 80%
on-target rate. Reads were aligned against mouse genome version GRCm38 using
BWA. Duplicate marking, base call recalibration, and realignment around indels
were done using GATK v3.464. Somatic SNPs and small indels were called against
pooled non-infected conditions as germline control using Strelka v1.0.1165 and
annotated using SnpEff v4.3k66. CNV were determined using CONTRA v2.0867.
WGS was performed at BGI Tech Solutions, Hong Kong, using BGISEQ-500
with a paired-end (2 × 100bp) library protocol and a target coverage of 30-fold.
Reads were mapped to GRCm38 using BWA. CNV for WGS data were called using
ControlFreeC v10.868 and R package DNAcopy. Copy number segments with
absolute log2 ratio larger than 0.15 were called as gains or losses. Structural variants
were called using SvABA69. SNV and indels were called in a similar way as for
exome variants using GATK preprocessing and variant calling by Strelka.
For both exome and whole-genome sequencing, we kept only SNV and indels
with allelic proportions of at least 25% in order to remove subclonal variants
arising during expansion after treatment.
All tertiary analysis was done using R70, including package circlize71.
Gene set enrichment analysis (GSEA). Gene sets were used from MSigDB v6.2
(collections H, C2, C3, C5, C6, and C7)72,73 after mapping genes from mouse to
human genes using the HomoloGene database74. Additionally, lists of intestinal
stem cell signature genes31 and genes upregulated and downregulated during
activated β-catenin signaling32 were used. The GSEA75 was performed on genes
pre-ranked by gene expression-based log2 fold change between non-infected and
Wnt-independent organoids using the fgsea R package76 with 5000 permutations;
R v.3.4 was used (https://cran.r-project.org/). For each experiment, p values from
all gene sets were jointly adjusted for multiple testing using the method of
Benjamini–Hochberg (false discovery rate)77.
Statistical analysis. All graphs were prepared using GraphPad Prism version
8 software. Data are presented as mean ± SD (standard deviation), and p values
were calculated by two-sided unpaired Student’s t-test. For comet assays, one-way
ANOVA with respective post hoc analysis (Tukey’s test) was used to calculate p
values. Data were considered significant if p < 0.05. Unless stated otherwise, figures
represent three independent experiments.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
All RNA sequencing data are available from Gene Expression Omnibus (GEO) with ID
GSE140929. Whole-genome and exome sequencing data have been submitted to the
European Nucleotide Archive (ENA) under accession PRJEB35529. MSigDB v6.2 is
available from http://www.gsea-msigdb.org/gsea/downloads_archive.jsp. Homologene
build 68 is available from https://ftp.ncbi.nih.gov/pub/HomoloGene/. Gencode M12
mouse gene models were obtained from ftp://ftp.ebi.ac.uk/pub/databases/gencode/
Gencode_mouse/release_M12/. Other data supporting the findings of this study are
available within the paper and its Supplementary Information files, or from the
corresponding authors upon request. Source data are provided with this paper.
Code availability
All code is available from https://github.com/MPIIB-Department-TFMeyer/
Iftekhar_Colibactin. The DOI link is https://doi.org/10.5281/zenodo.432272978.
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